Global Internal Neuromodulation Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published: 2025-10-30

Pages: 159 Pages

Report ld: 5316244

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Internal Neuromodulation market is projected to grow from US$ 2438 million in 2024 to US$ 4044 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

Internal Neuromodulation Market Size(US$)

M= millions and B=billions

The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Internal Neuromodulation market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers. 
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Report Metric
Details
Report Title
Global Internal Neuromodulation Market Outlook, In‑Depth Analysis & Forecast to 2031
Forecasted Market Size in 2031
US$ 4044 million
CAGR(2025-2031)
7.6%
Market Size Available for Years
2025-2031
Global Internal Neuromodulation Companies Covered
Medtronic PLC
Abbott
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Abbott Laboratories
Nevro Corporation
NeuroSigma
MicroTransponder
Neuronetics
LivaNova PLC
Bioventus Inc
NeuroPace Inc
Global Internal Neuromodulation Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Internal Neuromodulation Market, Segment by Type
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Global Internal Neuromodulation Market, Segment by Application
Parkinsons Disease
Chronic Pain
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the Internal Neuromodulation study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
    1.1 Introduction to Internal Neuromodulation: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global Internal Neuromodulation Market Size by Type, 2020 VS 2024 VS 2031
        1.2.2 Spinal Cord Stimulator
        1.2.3 Deep Brain Stimulator
        1.2.4 Sacral Nerve Stimulator
        1.2.5 Vagus Nerve Stimulator
        1.2.6 Gastric Neuro Stimulator
    1.3 Market Segmentation by Application
        1.3.1 Global Internal Neuromodulation Market Size by Application, 2020 VS 2024 VS 2031
        1.3.2 Parkinsons Disease
        1.3.3 Chronic Pain
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global Internal Neuromodulation Revenue Estimates and Forecasts 2020-2031
    2.2 Global Internal Neuromodulation Revenue by Region
        2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
        2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
        2.2.3 Global Revenue Market Share by Region (2020-2031)
        2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
    3.1 Global Internal Neuromodulation Player Revenue Rankings and Profitability
        3.1.1 Global Revenue (Value) by Players (2020-2025)
        3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
        3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
        3.1.4 Gross Margin by Top Player (2020 VS 2024)
    3.2 Global Internal Neuromodulation Companies Headquarters and Service Footprint
    3.3 Main Product Type Market Size by Players
        3.3.1 Spinal Cord Stimulator Market Size by Players
        3.3.2 Deep Brain Stimulator Market Size by Players
        3.3.3 Sacral Nerve Stimulator Market Size by Players
        3.3.4 Vagus Nerve Stimulator Market Size by Players
        3.3.5 Gastric Neuro Stimulator Market Size by Players
    3.4 Global Internal Neuromodulation Market Concentration and Dynamics
        3.4.1 Global Market Concentration (CR5 and HHI)
        3.4.2 Entrant/Exit Impact Analysis
        3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
    4.1 Global Internal Neuromodulation Revenue Trends by Type
        4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
        4.1.2 Global Revenue Market Share by Type (2020-2031)
    4.2 Key Product Attributes and Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Global Downstream Application Analysis
    5.1 Global Internal Neuromodulation Revenue by Application
        5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
        5.1.2 Revenue Market Share by Application (2020-2031)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Downstream Customer Analysis
        5.2.1 Top Customers by Region
        5.2.2 Top Customers by Application

6 North America
    6.1 North America Market Size (2020-2031)
    6.2 North America Key Players Revenue in 2024
    6.3 North America Internal Neuromodulation Market Size by Type (2020-2031)
    6.4 North America Internal Neuromodulation Market Size by Application (2020-2031)
    6.5 North America Growth Accelerators and Market Barriers
    6.6 North America Internal Neuromodulation Market Size by Country
        6.6.1 North America Revenue Trends by Country
        6.6.2 US
        6.6.3 Canada
        6.6.4 Mexico

7 Europe
    7.1 Europe Market Size (2020-2031)
    7.2 Europe Key Players Revenue in 2024
    7.3 Europe Internal Neuromodulation Market Size by Type (2020-2031)
    7.4 Europe Internal Neuromodulation Market Size by Application (2020-2031)
    7.5 Europe Growth Accelerators and Market Barriers
    7.6 Europe Internal Neuromodulation Market Size by Country
        7.6.1 Europe Revenue Trends by Country
        7.6.2 Germany
        7.6.3 France
        7.6.4 U.K.
        7.6.5 Italy
        7.6.6 Russia

8 Asia-Pacific
    8.1 Asia-Pacific Market Size (2020-2031)
    8.2 Asia-Pacific Key Players Revenue in 2024
    8.3 Asia-Pacific Internal Neuromodulation Market Size by Type (2020-2031)
    8.4 Asia-Pacific Internal Neuromodulation Market Size by Application (2020-2031)
    8.5 Asia-Pacific Growth Accelerators and Market Barriers
    8.6 Asia-Pacific Internal Neuromodulation Market Size by Region
        8.6.1 Asia-Pacific Revenue Trends by Region
    8.7 China
    8.8 Japan
    8.9 South Korea
    8.10 Australia
    8.11 India
    8.12 Southeast Asia
        8.12.1 Indonesia
        8.12.2 Vietnam
        8.12.3 Malaysia
        8.12.4 Philippines
        8.12.5 Singapore

9 Central and South America
    9.1 Central and South America Market Size (2020-2031)
    9.2 Central and South America Key Players Revenue in 2024
    9.3 Central and South America Internal Neuromodulation Market Size by Type (2020-2031)
    9.4 Central and South America Internal Neuromodulation Market Size by Application (2020-2031)
    9.5 Central and South America Investment Opportunities and Key Challenges
    9.6 Central and South America Internal Neuromodulation Market Size by Country
        9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
        9.6.2 Brazil
        9.6.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Market Size (2020-2031)
    10.2 Middle East and Africa Key Players Revenue in 2024
    10.3 Middle East and Africa Internal Neuromodulation Market Size by Type (2020-2031)
    10.4 Middle East and Africa Internal Neuromodulation Market Size by Application (2020-2031)
    10.5 Middle East and Africa Investment Opportunities and Key Challenges
    10.6 Middle East and Africa Internal Neuromodulation Market Size by Country
        10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
        10.6.2 GCC Countries
        10.6.3 Israel
        10.6.4 Egypt
        10.6.5 South Africa

11 Corporate Profile
    11.1 Medtronic PLC
        11.1.1 Medtronic PLC Corporation Information
        11.1.2 Medtronic PLC Business Overview
        11.1.3 Medtronic PLC Internal Neuromodulation Product Features and Attributes
        11.1.4 Medtronic PLC Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.1.5 Medtronic PLC Internal Neuromodulation Revenue by Product in 2024
        11.1.6 Medtronic PLC Internal Neuromodulation Revenue by Application in 2024
        11.1.7 Medtronic PLC Internal Neuromodulation Revenue by Geographic Area in 2024
        11.1.8 Medtronic PLC Internal Neuromodulation SWOT Analysis
        11.1.9 Medtronic PLC Recent Developments
    11.2 Abbott
        11.2.1 Abbott Corporation Information
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Internal Neuromodulation Product Features and Attributes
        11.2.4 Abbott Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.2.5 Abbott Internal Neuromodulation Revenue by Product in 2024
        11.2.6 Abbott Internal Neuromodulation Revenue by Application in 2024
        11.2.7 Abbott Internal Neuromodulation Revenue by Geographic Area in 2024
        11.2.8 Abbott Internal Neuromodulation SWOT Analysis
        11.2.9 Abbott Recent Developments
    11.3 Boston Scientific Corp.
        11.3.1 Boston Scientific Corp. Corporation Information
        11.3.2 Boston Scientific Corp. Business Overview
        11.3.3 Boston Scientific Corp. Internal Neuromodulation Product Features and Attributes
        11.3.4 Boston Scientific Corp. Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.3.5 Boston Scientific Corp. Internal Neuromodulation Revenue by Product in 2024
        11.3.6 Boston Scientific Corp. Internal Neuromodulation Revenue by Application in 2024
        11.3.7 Boston Scientific Corp. Internal Neuromodulation Revenue by Geographic Area in 2024
        11.3.8 Boston Scientific Corp. Internal Neuromodulation SWOT Analysis
        11.3.9 Boston Scientific Corp. Recent Developments
    11.4 Cerbomed GMBH
        11.4.1 Cerbomed GMBH Corporation Information
        11.4.2 Cerbomed GMBH Business Overview
        11.4.3 Cerbomed GMBH Internal Neuromodulation Product Features and Attributes
        11.4.4 Cerbomed GMBH Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.4.5 Cerbomed GMBH Internal Neuromodulation Revenue by Product in 2024
        11.4.6 Cerbomed GMBH Internal Neuromodulation Revenue by Application in 2024
        11.4.7 Cerbomed GMBH Internal Neuromodulation Revenue by Geographic Area in 2024
        11.4.8 Cerbomed GMBH Internal Neuromodulation SWOT Analysis
        11.4.9 Cerbomed GMBH Recent Developments
    11.5 Cyberonics
        11.5.1 Cyberonics Corporation Information
        11.5.2 Cyberonics Business Overview
        11.5.3 Cyberonics Internal Neuromodulation Product Features and Attributes
        11.5.4 Cyberonics Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.5.5 Cyberonics Internal Neuromodulation Revenue by Product in 2024
        11.5.6 Cyberonics Internal Neuromodulation Revenue by Application in 2024
        11.5.7 Cyberonics Internal Neuromodulation Revenue by Geographic Area in 2024
        11.5.8 Cyberonics Internal Neuromodulation SWOT Analysis
        11.5.9 Cyberonics Recent Developments
    11.6 Biocontrol Medical
        11.6.1 Biocontrol Medical Corporation Information
        11.6.2 Biocontrol Medical Business Overview
        11.6.3 Biocontrol Medical Internal Neuromodulation Product Features and Attributes
        11.6.4 Biocontrol Medical Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.6.5 Biocontrol Medical Recent Developments
    11.7 Depuy Synthes Companies
        11.7.1 Depuy Synthes Companies Corporation Information
        11.7.2 Depuy Synthes Companies Business Overview
        11.7.3 Depuy Synthes Companies Internal Neuromodulation Product Features and Attributes
        11.7.4 Depuy Synthes Companies Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.7.5 Depuy Synthes Companies Recent Developments
    11.8 Enteromedics
        11.8.1 Enteromedics Corporation Information
        11.8.2 Enteromedics Business Overview
        11.8.3 Enteromedics Internal Neuromodulation Product Features and Attributes
        11.8.4 Enteromedics Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.8.5 Enteromedics Recent Developments
    11.9 Synapse Biomedical
        11.9.1 Synapse Biomedical Corporation Information
        11.9.2 Synapse Biomedical Business Overview
        11.9.3 Synapse Biomedical Internal Neuromodulation Product Features and Attributes
        11.9.4 Synapse Biomedical Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.9.5 Synapse Biomedical Recent Developments
    11.10 Uroplasty
        11.10.1 Uroplasty Corporation Information
        11.10.2 Uroplasty Business Overview
        11.10.3 Uroplasty Internal Neuromodulation Product Features and Attributes
        11.10.4 Uroplasty Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.10.5 Company Ten Recent Developments
    11.11 Greatbatch
        11.11.1 Greatbatch Corporation Information
        11.11.2 Greatbatch Business Overview
        11.11.3 Greatbatch Internal Neuromodulation Product Features and Attributes
        11.11.4 Greatbatch Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.11.5 Greatbatch Recent Developments
    11.12 Abbott Laboratories
        11.12.1 Abbott Laboratories Corporation Information
        11.12.2 Abbott Laboratories Business Overview
        11.12.3 Abbott Laboratories Internal Neuromodulation Product Features and Attributes
        11.12.4 Abbott Laboratories Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.12.5 Abbott Laboratories Recent Developments
    11.13 Nevro Corporation
        11.13.1 Nevro Corporation Corporation Information
        11.13.2 Nevro Corporation Business Overview
        11.13.3 Nevro Corporation Internal Neuromodulation Product Features and Attributes
        11.13.4 Nevro Corporation Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.13.5 Nevro Corporation Recent Developments
    11.14 NeuroSigma
        11.14.1 NeuroSigma Corporation Information
        11.14.2 NeuroSigma Business Overview
        11.14.3 NeuroSigma Internal Neuromodulation Product Features and Attributes
        11.14.4 NeuroSigma Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.14.5 NeuroSigma Recent Developments
    11.15 MicroTransponder
        11.15.1 MicroTransponder Corporation Information
        11.15.2 MicroTransponder Business Overview
        11.15.3 MicroTransponder Internal Neuromodulation Product Features and Attributes
        11.15.4 MicroTransponder Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.15.5 MicroTransponder Recent Developments
    11.16 Neuronetics
        11.16.1 Neuronetics Corporation Information
        11.16.2 Neuronetics Business Overview
        11.16.3 Neuronetics Internal Neuromodulation Product Features and Attributes
        11.16.4 Neuronetics Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.16.5 Neuronetics Recent Developments
    11.17 LivaNova PLC
        11.17.1 LivaNova PLC Corporation Information
        11.17.2 LivaNova PLC Business Overview
        11.17.3 LivaNova PLC Internal Neuromodulation Product Features and Attributes
        11.17.4 LivaNova PLC Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.17.5 LivaNova PLC Recent Developments
    11.18 Bioventus Inc
        11.18.1 Bioventus Inc Corporation Information
        11.18.2 Bioventus Inc Business Overview
        11.18.3 Bioventus Inc Internal Neuromodulation Product Features and Attributes
        11.18.4 Bioventus Inc Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.18.5 Bioventus Inc Recent Developments
    11.19 NeuroPace Inc
        11.19.1 NeuroPace Inc Corporation Information
        11.19.2 NeuroPace Inc Business Overview
        11.19.3 NeuroPace Inc Internal Neuromodulation Product Features and Attributes
        11.19.4 NeuroPace Inc Internal Neuromodulation Revenue and Gross Margin (2020-2025)
        11.19.5 NeuroPace Inc Recent Developments

12 Internal NeuromodulationIndustry Chain Analysis
    12.1 Internal Neuromodulation Industry Chain
    12.2 Upstream Analysis
        12.2.1 Upstream Key Suppliers
    12.3 Middlestream Analysis
    12.4 Downstream Sales Model and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 Internal Neuromodulation Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Internal Neuromodulation Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Internal Neuromodulation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Internal Neuromodulation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Internal Neuromodulation Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Internal Neuromodulation Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Internal Neuromodulation Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Internal Neuromodulation Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Internal Neuromodulation by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2024)
 Table 11. Global Internal Neuromodulation Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Internal Neuromodulation Companies Headquarters
 Table 13. Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Internal Neuromodulation Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Internal Neuromodulation Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Internal Neuromodulation Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Internal Neuromodulation Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Internal Neuromodulation High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Internal Neuromodulation Growth Accelerators and Market Barriers
 Table 25. North America Internal Neuromodulation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Internal Neuromodulation Growth Accelerators and Market Barriers
 Table 27. Europe Internal Neuromodulation Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Internal Neuromodulation Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Internal Neuromodulation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Internal Neuromodulation Investment Opportunities and Key Challenges
 Table 31. Central and South America Internal Neuromodulation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Internal Neuromodulation Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Internal Neuromodulation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Medtronic PLC Corporation Information
 Table 35. Medtronic PLC Description and Major Businesses
 Table 36. Medtronic PLC Product Features and Attributes
 Table 37. Medtronic PLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Medtronic PLC Revenue Proportion by Product in 2024
 Table 39. Medtronic PLC Revenue Proportion by Application in 2024
 Table 40. Medtronic PLC Revenue Proportion by Geographic Area in 2024
 Table 41. Medtronic PLC Internal Neuromodulation SWOT Analysis
 Table 42. Medtronic PLC Recent Developments
 Table 43. Abbott Corporation Information
 Table 44. Abbott Description and Major Businesses
 Table 45. Abbott Product Features and Attributes
 Table 46. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Abbott Revenue Proportion by Product in 2024
 Table 48. Abbott Revenue Proportion by Application in 2024
 Table 49. Abbott Revenue Proportion by Geographic Area in 2024
 Table 50. Abbott Internal Neuromodulation SWOT Analysis
 Table 51. Abbott Recent Developments
 Table 52. Boston Scientific Corp. Corporation Information
 Table 53. Boston Scientific Corp. Description and Major Businesses
 Table 54. Boston Scientific Corp. Product Features and Attributes
 Table 55. Boston Scientific Corp. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Boston Scientific Corp. Revenue Proportion by Product in 2024
 Table 57. Boston Scientific Corp. Revenue Proportion by Application in 2024
 Table 58. Boston Scientific Corp. Revenue Proportion by Geographic Area in 2024
 Table 59. Boston Scientific Corp. Internal Neuromodulation SWOT Analysis
 Table 60. Boston Scientific Corp. Recent Developments
 Table 61. Cerbomed GMBH Corporation Information
 Table 62. Cerbomed GMBH Description and Major Businesses
 Table 63. Cerbomed GMBH Product Features and Attributes
 Table 64. Cerbomed GMBH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Cerbomed GMBH Revenue Proportion by Product in 2024
 Table 66. Cerbomed GMBH Revenue Proportion by Application in 2024
 Table 67. Cerbomed GMBH Revenue Proportion by Geographic Area in 2024
 Table 68. Cerbomed GMBH Internal Neuromodulation SWOT Analysis
 Table 69. Cerbomed GMBH Recent Developments
 Table 70. Cyberonics Corporation Information
 Table 71. Cyberonics Description and Major Businesses
 Table 72. Cyberonics Product Features and Attributes
 Table 73. Cyberonics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Cyberonics Revenue Proportion by Product in 2024
 Table 75. Cyberonics Revenue Proportion by Application in 2024
 Table 76. Cyberonics Revenue Proportion by Geographic Area in 2024
 Table 77. Cyberonics Internal Neuromodulation SWOT Analysis
 Table 78. Cyberonics Recent Developments
 Table 79. Biocontrol Medical Corporation Information
 Table 80. Biocontrol Medical Description and Major Businesses
 Table 81. Biocontrol Medical Product Features and Attributes
 Table 82. Biocontrol Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Biocontrol Medical Recent Developments
 Table 84. Depuy Synthes Companies Corporation Information
 Table 85. Depuy Synthes Companies Description and Major Businesses
 Table 86. Depuy Synthes Companies Product Features and Attributes
 Table 87. Depuy Synthes Companies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Depuy Synthes Companies Recent Developments
 Table 89. Enteromedics Corporation Information
 Table 90. Enteromedics Description and Major Businesses
 Table 91. Enteromedics Product Features and Attributes
 Table 92. Enteromedics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Enteromedics Recent Developments
 Table 94. Synapse Biomedical Corporation Information
 Table 95. Synapse Biomedical Description and Major Businesses
 Table 96. Synapse Biomedical Product Features and Attributes
 Table 97. Synapse Biomedical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Synapse Biomedical Recent Developments
 Table 99. Uroplasty Corporation Information
 Table 100. Uroplasty Description and Major Businesses
 Table 101. Uroplasty Product Features and Attributes
 Table 102. Uroplasty Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Uroplasty Recent Developments
 Table 104. Greatbatch Corporation Information
 Table 105. Greatbatch Description and Major Businesses
 Table 106. Greatbatch Product Features and Attributes
 Table 107. Greatbatch Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Greatbatch Recent Developments
 Table 109. Abbott Laboratories Corporation Information
 Table 110. Abbott Laboratories Description and Major Businesses
 Table 111. Abbott Laboratories Product Features and Attributes
 Table 112. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Abbott Laboratories Recent Developments
 Table 114. Nevro Corporation Corporation Information
 Table 115. Nevro Corporation Description and Major Businesses
 Table 116. Nevro Corporation Product Features and Attributes
 Table 117. Nevro Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Nevro Corporation Recent Developments
 Table 119. NeuroSigma Corporation Information
 Table 120. NeuroSigma Description and Major Businesses
 Table 121. NeuroSigma Product Features and Attributes
 Table 122. NeuroSigma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. NeuroSigma Recent Developments
 Table 124. MicroTransponder Corporation Information
 Table 125. MicroTransponder Description and Major Businesses
 Table 126. MicroTransponder Product Features and Attributes
 Table 127. MicroTransponder Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. MicroTransponder Recent Developments
 Table 129. Neuronetics Corporation Information
 Table 130. Neuronetics Description and Major Businesses
 Table 131. Neuronetics Product Features and Attributes
 Table 132. Neuronetics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Neuronetics Recent Developments
 Table 134. LivaNova PLC Corporation Information
 Table 135. LivaNova PLC Description and Major Businesses
 Table 136. LivaNova PLC Product Features and Attributes
 Table 137. LivaNova PLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. LivaNova PLC Recent Developments
 Table 139. Bioventus Inc Corporation Information
 Table 140. Bioventus Inc Description and Major Businesses
 Table 141. Bioventus Inc Product Features and Attributes
 Table 142. Bioventus Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Bioventus Inc Recent Developments
 Table 144. NeuroPace Inc Corporation Information
 Table 145. NeuroPace Inc Description and Major Businesses
 Table 146. NeuroPace Inc Product Features and Attributes
 Table 147. NeuroPace Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. NeuroPace Inc Recent Developments
 Table 149. Raw Materials Key Suppliers
 Table 150. Distributors List
 Table 151. Market Trends and Market Evolution
 Table 152. Market Drivers and Opportunities
 Table 153. Market Challenges, Risks, and Restraints
 Table 154. Research Programs/Design for This Report
 Table 155. Key Data Information from Secondary Sources
 Table 156. Key Data Information from Primary Sources


List of Figures
 Figure 1. Internal Neuromodulation Product Picture
 Figure 2. Global Internal Neuromodulation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Spinal Cord Stimulator Product Picture
 Figure 4. Deep Brain Stimulator Product Picture
 Figure 5. Sacral Nerve Stimulator Product Picture
 Figure 6. Vagus Nerve Stimulator Product Picture
 Figure 7. Gastric Neuro Stimulator Product Picture
 Figure 8. Global Internal Neuromodulation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Parkinsons Disease
 Figure 10. Chronic Pain
 Figure 11. Others
 Figure 12. Internal Neuromodulation Report Years Considered
 Figure 13. Global Internal Neuromodulation Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Internal Neuromodulation Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Internal Neuromodulation Revenue Market Share by Region (2020-2031)
 Figure 17. Global Internal Neuromodulation Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Spinal Cord Stimulator Revenue Market Share by Player in 2024
 Figure 20. Deep Brain Stimulator Revenue Market Share by Player in 2024
 Figure 21. Sacral Nerve Stimulator Revenue Market Share by Player in 2024
 Figure 22. Vagus Nerve Stimulator Revenue Market Share by Player in 2024
 Figure 23. Gastric Neuro Stimulator Revenue Market Share by Player in 2024
 Figure 24. Global Internal Neuromodulation Revenue Market Share by Type (2020-2031)
 Figure 25. Global Internal Neuromodulation Revenue Market Share by Application (2020-2031)
 Figure 26. North America Internal Neuromodulation Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Internal Neuromodulation Revenue (US$ Million) in 2024
 Figure 28. North America Internal Neuromodulation Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Internal Neuromodulation Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Internal Neuromodulation Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Internal Neuromodulation Revenue (US$ Million) in 2024
 Figure 35. Europe Internal Neuromodulation Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Internal Neuromodulation Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 38. France Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Internal Neuromodulation Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Internal Neuromodulation Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Internal Neuromodulation Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Internal Neuromodulation Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 50. India Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Internal Neuromodulation Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Internal Neuromodulation Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Internal Neuromodulation Revenue (US$ Million) in 2024
 Figure 58. Central and South America Internal Neuromodulation Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Internal Neuromodulation Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Internal Neuromodulation Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Internal Neuromodulation Revenue (US$ Million) in 2024
 Figure 64. South America Internal Neuromodulation Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Internal Neuromodulation Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Internal Neuromodulation Revenue (2020-2025) & (US$ Million)
 Figure 70. Internal Neuromodulation Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed

Description

The global Internal Neuromodulation market is projected to grow from US$ 2438 million in 2024 to US$ 4044 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Internal Neuromodulation market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers. 
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Related Reports

Global Internal Neuromodulation Market Research Report 2024
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
Published: 2024-01-31
Pages: 97
USD 2900.00
(Single User License)
Internal Neuromodulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Internal Neuromodulation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 115
USD 3950.00
(Single User License)
Global Internal Neuromodulation Market Insights, Forecast to 2030
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
Published: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Global Internal Neuromodulation Market Research Report 2025
The global market for Internal Neuromodulation was valued at US$ 2438 million in the year 2024 and is projected to reach a revised size of US$ 4044 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-02-25
Pages: 97
USD 2900.00
(Single User License)
Internal Neuromodulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Internal Neuromodulation was estimated to be worth US$ 2438 million in 2024 and is forecast to a readjusted size of US$ 4044 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 129
USD 3950.00
(Single User License)
Global Internal Neuromodulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Internal Neuromodulation market size was US$ 2438 million in 2024 and is forecast to a readjusted size of US$ 4044 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 102
USD 4250.00
(Single User License)